ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2022

FOXM1 Inhibition Enhances the Therapeutic Outcome of Lung Cancer Immunotherapy by Modulating PD-L1 Expression and Cell Proliferation.

Hamadi Madhi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.